|
Jan 15
|
GKOS Stock Gains Following Positive Study Data on iDose Platform
|
|
Jan 14
|
Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform
|
|
Jan 4
|
Glaukos price target raised to $157 from $149 at BTIG
|
|
Oct 17
|
GKOS Stock Rises on Positive Phase 3 Confirmatory Trial for Epioxa
|
|
Oct 17
|
Glaukos eyes FDA approval for ocular therapy after Phase III win
|
|
Oct 16
|
Glaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa™, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and Safety
|
|
Oct 14
|
Glaukos To Present Multiple Scientific Abstracts at the 2024 American Academy of Ophthalmology Annual Meeting
|
|
Jul 30
|
Will These 4 MedTech Stocks Beat Forecasts This Earnings Season?
|
|
Jul 30
|
A Look At The Fair Value Of Glaukos Corporation (NYSE:GKOS)
|
|
Jul 25
|
Earnings Preview: Teleflex (TFX) Q2 Earnings Expected to Decline
|
|
Jul 24
|
Glaukos (GKOS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Jul 15
|
Is a Beat Likely for Edwards Lifesciences (EW) in Q2 Earnings?
|
|
May 28
|
Glaukos Announces Participation in Upcoming Investor Conferences
|
|
May 14
|
Glaukos (GKOS) Reaches 52-Week High: What's Aiding the Stock?
|
|
May 8
|
Earnings Update: Here's Why Analysts Just Lifted Their Glaukos Corporation (NYSE:GKOS) Price Target To US$113
|
|
May 2
|
Glaukos (GKOS) Q1 Earnings Miss Estimates, Revenues Up Y/Y
|
|
May 2
|
Q1 2024 Glaukos Corp Earnings Call
|
|
May 2
|
Glaukos Corp (GKOS) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic ...
|
|
May 1
|
Glaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 1
|
Glaukos Corp (GKOS) Q1 2024 Earnings: Misses Analyst EPS Forecast, Surpasses Revenue Expectations
|